Bioventus (BVS) EBIT Margin (QoQ) (2020 - 2026)
Bioventus (BVS) EBIT Margin (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.61 Bn | 194.01 Bn | 7.27 Bn |
| 2 | Stryker | 127.81 Bn | 124.34 Bn | 4.50 Bn |
| 3 | Medtronic | 119.04 Bn | 109.82 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.68 Bn | 73.14 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.96 Bn | 47.71 Bn | 1.35 Bn |
| 6 | Dexcom | 34.36 Bn | 32.41 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.83 Bn | 31.72 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn |
| 9 | Steris | 23.06 Bn | 22.58 Bn | 684.20 Mn |
| 10 | Bioventus | 966.46 Mn | 937.00 Mn | 105.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | 611.00 |
| Mar 28, 2026 | -597.00 |
| Dec 31, 2025 | 423.00 |
| Sep 27, 2025 | -432.00 |
| Jun 28, 2025 | 851.00 |
| Mar 29, 2025 | -108.00 |
| Dec 31, 2024 | 239.00 |
| Sep 28, 2024 | 2,344.00 |
| Jun 29, 2024 | -2,462.00 |
| Mar 30, 2024 | 295.00 |
| Dec 31, 2023 | -114.00 |
| Sep 30, 2023 | -292.00 |
| Jul 1, 2023 | 8,225.00 |
| Apr 1, 2023 | -6,489.00 |
| Dec 31, 2022 | 8,616.00 |
| Oct 1, 2022 | -9,623.00 |
| Jul 2, 2022 | 1,593.00 |
| Apr 2, 2022 | -1,587.00 |
| Dec 31, 2021 | -145.00 |
| Oct 2, 2021 | 427.00 |